Reimbursed with a limitationOriginator productATC L01FY02

Opdualag

Opdualag is an originator product from Bristol-Myers Squibb SA and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 5'960.15 to CHF 5'960.15 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder: Bristol-Myers Squibb SA
ATC code: L01FY02
IT group: 07.16.10 Cytostatica
Active substances: Relatlimabum, Nivolumabum
Preparation type: Originator product
On the SL since: 01/02/2024
Last price change: 01/01/2026
Co-payment: 10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Opdualag Price table As of 17/09/2026
Dosage form	Pack size	Ex-factory price	Public price	Valid from	Cat.	GTIN
Inf Konz	Durchstf 20 ml	CHF 5'509.10	CHF 5'960.15	01/02/2024	A	7680686090019

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingIndication 21515.01Valid from 01/01/2026

OPDUALAG ist für die Erstlinienbehandlung von Erwachsenen mit nicht resezierbarem oder metastasiertem Melanom mit einer PD-L1-Expression Bristol Myers Squibb erstattet dem Krankenversicherer, bei dem die versicherte Person zum Zeitpunkt des Bezugs versichert war, für jede bezogene Packung einen festgelegten Anteil des Fabrikabgabepreises zurück. Sie gibt dem Krankenversicherer die Höhe der Rückerstattung bekannt. Die Mehrwertsteuer kann nicht zusätzlich zu diesem Anteil des Fabrikabgabepreises zurückgefordert werden. Die Aufforderung zur Rückerstattung soll ab dem Zeitpunkt der Verabreichung erfolgen.
Folgender Code ist an den Krankenversicherer zu übermitteln: 21515.01

FAQ

Is Opdualag covered by Swiss health insurance?

Yes, but only under conditions. Opdualag is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Opdualag cost in Switzerland?

The public price is the maximum price set by the FOPH and for Opdualag ranges from CHF 5'960.15 to CHF 5'960.15 per pack. The ex-factory price ranges from CHF 5'509.10 to CHF 5'509.10. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

Independent directory
Official FOPH data
Website in eight languages

Request a market access call View information